Jonathan Siegal, Principal Accounting Officer of Vericel Corp (NASDAQ:VCEL), filed a Form 4 on November 17, 2026, disclosing a series of stock option exercises and same-day share sales on November 13, 2026.
Key Highlights
- Three option exercises: Siegal exercised options covering 263 shares at $34.90, 935 shares at $34.90, and 687 shares at $29.82, all on November 13, 2026.
- Same-day sales: The filing reports disposals of 263 shares at $57.78, 935 shares at $57.62, and 687 shares at $57.80, each on November 13, 2026.
- Resulting ownership: Following all reported transactions, Siegal directly held 1,259 shares of common stock.
- Remaining options: After the exercises, Siegal retained 935 options expiring 02/18/2032 and 2,813 options expiring 02/17/2033, according to the filing.
- ESPP shares noted: The filing states that the share totals include shares acquired under the issuer's 2015 Employee Stock Purchase Plan in transactions exempt under Rule 16b-3(d) and Rule 16b-3(c).
Siegal's Option Exercises and Sales at Vericel Corp on November 13, 2026
According to the Form 4 filed with the SEC, Jonathan Siegal, identified as Principal Accounting Officer of Vericel Corp, carried out six transactions in Vericel common stock on November 13, 2026. The transactions involved the exercise of three separate stock option tranches, each followed by a same-day sale of the acquired shares.
The filing reports that Siegal first exercised an option to acquire 263 shares at an exercise price of $34.90 per share (transaction code M), bringing his direct holdings to 1,522 shares, and then sold those 263 shares at $57.78 per share (transaction code S), reducing his direct holdings to 1,259 shares. He then exercised a second tranche of 935 shares, also at $34.90 per share, increasing his holdings to 2,194 shares, before selling those 935 shares at $57.62 per share, returning his holdings to 1,259 shares. A third tranche of 687 shares was exercised at $29.82 per share, raising holdings to 1,946 shares, followed by a sale of those 687 shares at $57.80 per share, leaving Siegal with a reported direct beneficial ownership of 1,259 shares.
The filing notes that the first two option tranches (263 and 935 shares) relate to a grant of 4,198 total shares, with an expiration date of 02/18/2032, and the third tranche (687 shares) relates to a grant of 9,000 total shares, with an expiration date of 02/17/2033. Both grants, the filing states, became exercisable in equal quarterly installments contingent upon continued service. The Form 4 was signed by Sean Flynn as Attorney-in-Fact for Jonathan Siegal.
What Was Disclosed
The filing discloses three option exercises and three same-day open-market sales of Vericel Corp common stock by Principal Accounting Officer Jonathan Siegal on November 13, 2026, resulting in direct beneficial ownership of 1,259 shares following all reported transactions.



Please wait processing your request...